The Under Secretary for Health ensures that the Clinical Episode Review Team reviews the OIG-provided biomedical equipment manufacturer’s information for the automated endoscope reprocessor to determine if the information alters their determination regarding the potential risk to patients or the need for a large-scale disclosure and takes action as necessary.
Questioned Costs
$0
Funds for Better Use
$0
Recommendation Status
Closed
Source UUID
20-02265-100-2
Recommendation Number
2
Significant Recommendation
Yes